NO20065485L - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number
NO20065485L
NO20065485L NO20065485A NO20065485A NO20065485L NO 20065485 L NO20065485 L NO 20065485L NO 20065485 A NO20065485 A NO 20065485A NO 20065485 A NO20065485 A NO 20065485A NO 20065485 L NO20065485 L NO 20065485L
Authority
NO
Norway
Prior art keywords
chemical connections
smilagenin
connections
chemical
hydrated
Prior art date
Application number
NO20065485A
Other languages
English (en)
Norwegian (no)
Inventor
Peter David Tiffin
Original Assignee
Phytopharm Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytopharm Plc filed Critical Phytopharm Plc
Publication of NO20065485L publication Critical patent/NO20065485L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
NO20065485A 2004-04-28 2006-11-28 Kjemiske forbindelser NO20065485L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0409567.5A GB0409567D0 (en) 2004-04-28 2004-04-28 Chemical compounds
PCT/GB2005/001635 WO2005105825A2 (en) 2004-04-28 2005-04-28 Crystalline and amorphous forms of smilagenin

Publications (1)

Publication Number Publication Date
NO20065485L true NO20065485L (no) 2007-01-29

Family

ID=32408243

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065485A NO20065485L (no) 2004-04-28 2006-11-28 Kjemiske forbindelser

Country Status (17)

Country Link
US (2) US20080004249A1 (pt)
EP (2) EP2402362A2 (pt)
JP (1) JP2007534736A (pt)
KR (1) KR20070028387A (pt)
CN (2) CN101076539A (pt)
AU (1) AU2005238274A1 (pt)
BR (1) BRPI0510458A (pt)
CA (1) CA2564368A1 (pt)
GB (1) GB0409567D0 (pt)
IL (1) IL178870A0 (pt)
MX (1) MXPA06012641A (pt)
NO (1) NO20065485L (pt)
RU (1) RU2006141389A (pt)
SG (1) SG155165A1 (pt)
TW (1) TW200538145A (pt)
WO (1) WO2005105825A2 (pt)
ZA (1) ZA200609596B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010084356A1 (en) 2009-01-24 2010-07-29 Phytopharm Plc Treatment of neurotrophic factor mediated disorders
AU2011281336B2 (en) 2010-07-20 2015-03-05 Junaxo, Inc. Treatment of L-DOPA, dopamine agonist and/or dopamine enhancer induced disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL292786A (pt) * 1962-05-15
US3169959A (en) * 1963-07-23 1965-02-16 Intermediates Inc Method of obtaining smilagenin
CA985172A (en) 1972-10-06 1976-03-09 Dushan M. Dvornik Compositions and methods for reducing blood cholesterol
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
US4680289A (en) 1985-06-05 1987-07-14 Progenics, Inc. Treatment of obesity and diabetes using sapogenins
US5017562A (en) 1987-02-11 1991-05-21 Regents Of The University Of Minnesota Crystalline saponin-containing complex
PL195897B1 (pl) * 1998-03-26 2007-11-30 Phytopharm Plc Zastosowanie smilageniny
GB9905275D0 (en) 1999-03-08 1999-04-28 Phytopharm Ltd Treatment of conditions associated with membrane-bound receptors and their function
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
AT409100B (de) 2000-07-24 2002-05-27 Evg Entwicklung Verwert Ges Vorrichtung zum schweissen einer drahtgittermatte
GB0107822D0 (en) 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
KR20100093621A (ko) 2002-03-27 2010-08-25 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 용도
PL210114B1 (pl) 2002-10-28 2011-12-30 Phytopharm Plc Sposób stereospecyficznego wytwarzania 3β-hydroksy-5β-H-steroidowych sapogenin

Also Published As

Publication number Publication date
CN101076539A (zh) 2007-11-21
CN102516352A (zh) 2012-06-27
AU2005238274A1 (en) 2005-11-10
KR20070028387A (ko) 2007-03-12
WO2005105825A3 (en) 2006-02-23
CA2564368A1 (en) 2005-11-10
JP2007534736A (ja) 2007-11-29
SG155165A1 (en) 2009-09-30
RU2006141389A (ru) 2008-06-10
BRPI0510458A (pt) 2007-10-30
MXPA06012641A (es) 2006-12-15
WO2005105825A2 (en) 2005-11-10
IL178870A0 (en) 2007-03-08
US20110144323A1 (en) 2011-06-16
GB0409567D0 (en) 2004-06-02
EP1742960A2 (en) 2007-01-17
EP2402362A2 (en) 2012-01-04
ZA200609596B (en) 2008-01-30
US20080004249A1 (en) 2008-01-03
TW200538145A (en) 2005-12-01

Similar Documents

Publication Publication Date Title
NO20054905D0 (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
ATE483752T1 (de) Wässrige dispersion, herstellungsverfahren dafür und verwendung davon
NO20071549L (no) Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler
ZA201201391B (en) Methods, compositions, and kits for the treatment of medical conditions
NO20080010L (no) GPCR-agonister
ZA200804079B (en) Parthenogenic activation of human oocytes for the production of human embroyonic stem cells
NO20055686L (no) Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
NO20055204D0 (no) Derivater av piperidinyl- og pipemzinylalkylkarbamater, fremgangsmater for fremstilling derav og anvendelse av de samme i terapi
ME01394B (me) Kristalni oblik gama-d ivabradin hlorhidrata, postupak njegove izrade i farmaceutske smeše koje ga sadrže
DK1670458T3 (da) 1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika
NO20051503D0 (no) Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
DK1928840T3 (da) 1H-pyrazol-4-carboxamider, deres fremstilling og deres anvendelse som 11-beta-hydroxysteroid-dehydrogenaseinhibitorer
PT1893224T (pt) Utilização de uma membrana de célula vegetal para o tratamento da obesidade
UA91848C2 (ru) Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
NO20055741D0 (no) Nye kjemiske forbindelser
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
DE502004005907D1 (de) Selbstemulgierende wässrige polyurethandispersionen
NO20080034L (no) Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer
NO20072794L (no) Kjemiske forbindelser
DK1718340T3 (da) Nye effektorkonjugater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
NO20064715L (no) Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C)
NO20065485L (no) Kjemiske forbindelser
EP1743531A4 (en) ANIMAL CROP CARRIER, USE, FOOD AND METHOD OF MANUFACTURING THEREOF
DK1634589T3 (da) Vandig olanexidinopløsning, fremgangsmåde til fremstilling heraf og desinfektionsmiddel
DK1727805T3 (da) 1-phenyl- og 1-pyridylpyrazolderivater og anvendelse deraf som pesticider

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application